Axsome Therapeutics, Inc.
AXSM
Clasificación en acciones
#2362
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to... Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
Precio por acción
$159.65
Última sincronización: 2026-10-20
Capitalización bursátil
$8.36B
Cambio (1 día)
2.46%
Cambio (1 año)
21.51%
País
US
Comercio Axsome Therapeutics, Inc. (AXSM)
Categoría
Healthcare
Número de acciones en circulación de Axsome Therapeutics, Inc. (AXSM)
Número de acciones en circulación al June 2026: 51.50M
Según los últimos informes financieros y el precio de las acciones de Axsome Therapeutics, Inc., el número actual de acciones en circulación es 51.50M. Al final de December 2023, la empresa tenía 45.43M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Axsome Therapeutics, Inc. (AXSM) desde 2013 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 51.50M | 7.49% |
| 2024 | 47.91M | 5.48% |
| 2023 | 45.43M | 11.73% |
| 2022 | 40.66M | 8.07% |
| 2021 | 37.62M | 1.11% |
| 2020 | 37.21M | 9.37% |
| 2019 | 34.02M | 26.55% |
| 2018 | 26.88M | 18.09% |
| 2017 | 22.76M | 18.87% |
| 2016 | 19.15M | 60.32% |
| 2015 | 11.95M | -6.08% |
| 2014 | 12.72M | 62.59% |
| 2013 | 7.82M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 253.90M | 393.00% |
US
|
|
| 396.00M | 668.92% |
US
|
|
| 478.91M | 829.91% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 20.75% |
NL
|
